ARK Investment Management’s IceCure Medical ICCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-15,496
Closed -$1.4M 366
2021
Q4
$1.4M Buy
15,496
+5,056
+48% +$845K ﹤0.01% 251
2021
Q3
$2.73M Buy
+10,440
New +$3.09M 0.01% 240

Other funds holding ICCM

ARK Investment Management's ICCM Position: Q1 2022 in Review

ARK Investment Management sold out of IceCure Medical (ICCM) in Q1 2022, closing a stake of 15,496 shares — an estimated $1.4M sold.

ARK Investment Management first reported a position in ICCM in Q3 2021 and held it in 2 quarters. The position peaked at $2.73M in Q3 2021. 9 funds tracked by Wall St. Rank hold ICCM as of Q1 2022.

  • ARK Investment Management reported no remaining IceCure Medical position as of Q1 2022 after selling out during the quarter.
  • ARK Investment Management sold 15,496 IceCure Medical shares in Q1 2022, an estimated $1.4M.
  • ARK Investment Management first reported a position in IceCure Medical in Q3 2021 and held it in 2 quarters.
  • ARK Investment Management's IceCure Medical position peaked at $2.73M in Q3 2021.
  • 9 funds tracked by Wall St. Rank held IceCure Medical as of Q1 2022.

Based on ARK Investment Management's 13F filing for Q1 2022, filed 19 Apr 2022.